$ACN

Accenture Q4 2026 earnings beat sends stock up 22%

Accenture reported Q4 2026 revenue of $18.68B, up 6% YoY, and EPS of $3.29, beating estimates. Full-year revenue rose 6% to $74.18B, with EPS up 8%. Shares surged 22% on the results, the largest single-day gain on record, but are still down 18% YTD. The company raised its dividend by 5% and provided fiscal 2027 guidance.

Original reporting
Published Oct 1, 2026, 5:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 5:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Accenture Q4 2026 earnings beat sends stock up 22% — source image
Decision brief

The 30-second read

$ACNBullishHigh
01

Why it matters

The earnings beat and dividend increase are likely to attract both growth and income investors, supporting further upside.

02

Market read

The surprise earnings beat and sizable intraday rally make this a high‑impact news item for traders.

03

What to watch

Potential slowdown in U.S. federal government spending could temper longer‑term growth.

Relevance 9/10Novelty 9/10Timing: today

Background

Accenture's Q4 2026 results marked a turnaround after a challenging year, with revenue up 6% YoY and a record free cash flow return.

Company-level read

Ticker impact

$ACNBullishHigh confidence
Context

Accenture reported Q4 2026 earnings beat and raised dividend, sending the stock up 22% on the day.

Expected impact

upward pressure as investors price in the earnings beat and higher dividend.

Evidence & confidence

Earnings exceeded consensus, revenue beat, and dividend hike together constitute a material catalyst for a large-cap stock.

Market effects

Positive signal for the broader consulting and professional services sector.

U.S. market likely to see a modest lift in tech‑heavy indices.

Accenture's global footprint may boost sentiment in related overseas markets.

Counterpoint

Some investors may view the 22% rally as overbought and could target short positions on pull‑back.

Key entities

  • Accenture

    Global consulting and professional services firm.

Related articles

$ACNHighAI 9/10

Accenture (ACN) Shares Surge 21% Following Strong Q4 Earnings Be

Accenture (ACN) shares rose 21% after Q4 earnings of $3.29 per share beat estimates by $0.11. Revenue grew 6.3% YoY to $18.7B, exceeding forecasts. The company offered optimistic guidance for 2027, with revenue growth projected between 3% and 6%. Accenture's dividend yield is 2.96% with a payout ratio of 47%, and it has a GF Score of 87, indicating strong financial health.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.